Academic Unit of Clinical Oncology, University of Sheffield, Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.
Breast Cancer Res. 2012 May 25;14(3):R86. doi: 10.1186/bcr3201.
The majority of deaths from breast cancer are a result of metastases; however, little is understood about the genetic alterations underlying their onset. Genetic profiling has identified the adhesion molecule plakoglobin as being three-fold reduced in expression in primary breast tumors that have metastasized compared with nonmetastatic tumors. In this study, we demonstrate a functional role for plakoglobin in the shedding of tumor cells from the primary site into the circulation.
We investigated the effects of plakoglobin knockdown on breast cancer cell proliferation, migration, adhesion, and invasion in vitro and on tumor growth and intravasation in vivo. MCF7 and T47D cells were stably transfected with miRNA sequences targeting the plakoglobin gene, or scramble vector. Gene and protein expression was monitored by quantitative polymerase chain reaction (qPCR) and Western blot. Cell proliferation, adhesion, migration, and invasion were measured by cell counting, flow cytometry, and scratch and Boyden Chamber assays. For in vivo experiments, plakoglobin knockdown and control cells were inoculated into mammary fat pads of mice, and tumor growth, shedding of tumor cells into the bloodstream, and evidence of metastatic bone lesions were monitored with caliper measurement, flow cytometry, and microcomputed tomography (μCT), respectively.
Plakoglobin and γ-catenin expression were reduced by more than 80% in all knockdown cell lines used but were unaltered after transfection with the scrambled sequence. Reduced plakoglobin resulted in significantly increased in MCF7 and T47D cell proliferation in vitro and in vivo, compared with control, with significantly more tumor cells being shed into the bloodstream of mice bearing plakoglobin knockdown tumors. In addition, plakoglobin knockdown cells showed a >250% increase in invasion through basement membrane and exhibited reduced cell-to-cell adhesion compared with control cells.
Decreased plakoglobin expression increases the invasive behavior of breast cancer cells. This is the first demonstration of a functional role for plakoglobin/γ-catenin in the metastatic process, indicating that this molecule may represent a target for antimetastatic therapies.
大多数乳腺癌死亡是由于转移所致;然而,对于导致转移的遗传改变知之甚少。遗传分析已经确定,与非转移性肿瘤相比,在已经转移的原发性乳腺癌肿瘤中,黏附分子桥粒斑蛋白的表达减少了三倍。在这项研究中,我们证明了桥粒斑蛋白在肿瘤细胞从原发性部位脱落进入循环系统中的功能作用。
我们研究了桥粒斑蛋白敲低对 MCF7 和 T47D 细胞体外增殖、迁移、黏附和侵袭的影响,以及体内肿瘤生长和血管内渗的影响。用针对桥粒斑蛋白基因的 miRNA 序列或乱序载体稳定转染 MCF7 和 T47D 细胞。通过定量聚合酶链反应(qPCR)和 Western blot 监测基因和蛋白表达。通过细胞计数、流式细胞术和划痕和 Boyden 室测定来测量细胞增殖、黏附、迁移和侵袭。对于体内实验,将桥粒斑蛋白敲低和对照细胞接种到小鼠乳腺脂肪垫中,通过卡尺测量、流式细胞术和微计算机断层扫描(μCT)分别监测肿瘤生长、肿瘤细胞脱落到血液中以及转移性骨病变的证据。
所有使用的敲低细胞系中的桥粒斑蛋白和γ-连环蛋白表达减少了 80%以上,但用乱序序列转染后没有改变。与对照相比,MCF7 和 T47D 细胞中的桥粒斑蛋白减少导致体外和体内的增殖显著增加,并且带有桥粒斑蛋白敲低肿瘤的小鼠血液中有更多的肿瘤细胞脱落。此外,与对照细胞相比,桥粒斑蛋白敲低细胞穿过基底膜的侵袭增加了超过 250%,并且细胞间黏附减少。
桥粒斑蛋白表达的降低增加了乳腺癌细胞的侵袭行为。这是首次证明桥粒斑蛋白/γ-连环蛋白在转移过程中的功能作用,表明该分子可能成为抗转移治疗的靶点。